Bredin Prat advises LifeSciences Holding in connection with the acquisition of an ownership interest in the ‘community of heirs’ of Horst Walter Sartorius

Bredin Prat is advising LifeSciences Holding, a long-term oriented investor consortium led by investment holding, Armira, in the successful completion of the acquisition of interests representing approximately 40% of the ‘community of heirs’ of Horst Walter Sartorius from members of the Sartorius family.

The assets within the community of heirs include a total of 50.09% of the ordinary shares of the German company Sartorius AG, the parent company of Sartorium Stedim Biotech, and are not affected by the aforementioned transactions; the shares within the community of heirs will continue to be subject to execution of the will of testator Horst Sartorius by an executor until mid-2028.

The Bredin Prat team advising LifeSciences Holding on the French law aspects of the transaction comprises Benjamin Kanovitch and Adrien Simon (partners) assisted by Vianney Guillet de Chatellus (associate).

LifeSciences Holding is also advised by our Best Friend, Hengeler Mueller, on the German law aspects.